Suppr超能文献

相似文献

1
Structure and dynamics of the epidermal growth factor receptor C-terminal phosphorylation domain.
Protein Sci. 2006 May;15(5):1142-52. doi: 10.1110/ps.052045306. Epub 2006 Apr 5.
2
Conformational changes accompany phosphorylation of the epidermal growth factor receptor C-terminal domain.
Protein Sci. 2005 Nov;14(11):2793-803. doi: 10.1110/ps.051630305. Epub 2005 Sep 30.
6
Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor.
Biochemistry. 2008 Mar 11;47(10):3096-108. doi: 10.1021/bi701549a. Epub 2008 Feb 13.
7
Phosphorylation of Thr654 but not Thr669 within the juxtamembrane domain of the EGF receptor inhibits calmodulin binding.
Biochem Biophys Res Commun. 2006 Aug 25;347(2):381-7. doi: 10.1016/j.bbrc.2006.05.200. Epub 2006 Jun 9.
8
The juxtamembrane region of the epidermal growth factor receptor is required for phosphorylation of Galpha(s).
Arch Biochem Biophys. 2000 Nov 15;383(2):309-17. doi: 10.1006/abbi.2000.2095.
9
An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor.
Cell. 2006 Jun 16;125(6):1137-49. doi: 10.1016/j.cell.2006.05.013.

引用本文的文献

1
New advances in the treatment of EGFR exon20ins mutant advanced NSCLC.
Am J Cancer Res. 2025 Apr 25;15(4):1852-1873. doi: 10.62347/WTMU5537. eCollection 2025.
3
4
Pyrrolo[2,3-D]Pyrimidines as EGFR and VEGFR Kinase Inhibitors: A Comprehensive SAR Review.
Curr Med Chem. 2024;31(36):5918-5936. doi: 10.2174/0929867331666230815115111.
5
Ligand-induced transmembrane conformational coupling in monomeric EGFR.
Nat Commun. 2022 Jul 6;13(1):3709. doi: 10.1038/s41467-022-31299-z.
6
Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer.
Front Oncol. 2022 Mar 25;12:869672. doi: 10.3389/fonc.2022.869672. eCollection 2022.
7
Expanding the Disorder-Function Paradigm in the C-Terminal Tails of Erbbs.
Biomolecules. 2021 Nov 14;11(11):1690. doi: 10.3390/biom11111690.
9
The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors.
Beilstein J Nanotechnol. 2021 Apr 29;12:375-401. doi: 10.3762/bjnano.12.31. eCollection 2021.
10
Structural and dynamic characterization of the C-terminal tail of ErbB2: Disordered but not random.
Biophys J. 2021 May 18;120(10):1869-1882. doi: 10.1016/j.bpj.2021.03.005. Epub 2021 Mar 17.

本文引用的文献

1
Conformational changes accompany phosphorylation of the epidermal growth factor receptor C-terminal domain.
Protein Sci. 2005 Nov;14(11):2793-803. doi: 10.1110/ps.051630305. Epub 2005 Sep 30.
4
An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors.
Mol Cell. 2003 Sep;12(3):541-52. doi: 10.1016/s1097-2765(03)00350-2.
5
Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.
Cell. 2002 Sep 20;110(6):775-87. doi: 10.1016/s0092-8674(02)00963-7.
6
Ligand-induced, receptor-mediated dimerization and activation of EGF receptor.
Cell. 2002 Sep 20;110(6):669-72. doi: 10.1016/s0092-8674(02)00966-2.
7
Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor.
J Biol Chem. 2002 Nov 29;277(48):46265-72. doi: 10.1074/jbc.M207135200. Epub 2002 Aug 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验